| 000 | 01512 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250511194532.0 | ||
| 264 | 0 | _c19920806 | |
| 008 | 199208s 0 0 eng d | ||
| 022 | _a0001-6314 | ||
| 024 | 7 |
_a10.1111/j.1600-0404.1992.tb04053.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCaramelli, P | |
| 245 | 0 | 0 |
_aNeurological complications after thrombolytic treatment for acute myocardial infarction: emphasis on unprecedented manifestations. _h[electronic resource] |
| 260 |
_bActa neurologica Scandinavica _cMay 1992 |
||
| 300 |
_a331-3 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBrain Diseases _xdrug therapy |
| 650 | 0 | 4 |
_aCerebrovascular Disorders _xdrug therapy |
| 650 | 0 | 4 | _aEnzyme Activation |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFibrinolytic Agents |
| 650 | 0 | 4 |
_aHeparin _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMyocardial Infarction _xcomplications |
| 650 | 0 | 4 |
_aPhenytoin _xtherapeutic use |
| 650 | 0 | 4 |
_aSeizures _xdrug therapy |
| 650 | 0 | 4 | _aThrombolytic Therapy |
| 650 | 0 | 4 |
_aTissue Plasminogen Activator _xadministration & dosage |
| 700 | 1 | _aMutarelli, E G | |
| 700 | 1 | _aCaramelli, B | |
| 700 | 1 | _aTranchesi, B | |
| 700 | 1 | _aPileggi, F | |
| 700 | 1 | _aScaff, M | |
| 773 | 0 |
_tActa neurologica Scandinavica _gvol. 85 _gno. 5 _gp. 331-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1600-0404.1992.tb04053.x _zAvailable from publisher's website |
| 999 |
_c1627975 _d1627975 |
||